Experts Chat about Nanotechnology (Drug Discovery & Development)
- Experts in nanotechnology gathered today in an open online chat on Nanotechnology and Medicine, hosted by the American Association for the Advancement of Science. Several new areas of research were discussed and, while the scientists admit that nanoscience and nanotechnology are in the very early stages of development, they see a potential for tremendous positive impacts on medicine.
The panel included Richard Siegel, PhD, director of the Rensselaer Nanotechnology Center, Rensselaer Polytechnic Institute, Troy, N.Y., James Baker, Jr., PhD, founder of the Center for Biologic Nanotechnology, University of Michigan, Ann Arbor, Mich., and Jeffery Schloss, who coordinates the development of nanotechnology strategy for the National Institutes of Health through work with the National Human Genome Research Institute, Bethesda, Md.
“Nanotechnology really is a combination of nanoscience and a set of enabling technologies that utilize the fact that matter at very small length scales (less than 100 nanometers) have distinctly different properties than the same matter at larger length scales,” said Siegel. “Hence, the building blocks of matter below 100 nanometers can be used to create new materials and new devices for a wide range of applications that could not be created without nanotechnology.” More here
NanoDoctors hold online office hours